NL7108858A - - Google Patents

Info

Publication number
NL7108858A
NL7108858A NL7108858A NL7108858A NL7108858A NL 7108858 A NL7108858 A NL 7108858A NL 7108858 A NL7108858 A NL 7108858A NL 7108858 A NL7108858 A NL 7108858A NL 7108858 A NL7108858 A NL 7108858A
Authority
NL
Netherlands
Application number
NL7108858A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NL7108858A publication Critical patent/NL7108858A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16Purine radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
NL7108858A 1970-06-30 1971-06-25 NL7108858A (https=)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP5750770 1970-06-30

Publications (1)

Publication Number Publication Date
NL7108858A true NL7108858A (https=) 1972-01-03

Family

ID=13057634

Family Applications (1)

Application Number Title Priority Date Filing Date
NL7108858A NL7108858A (https=) 1970-06-30 1971-06-25

Country Status (8)

Country Link
US (1) US3796700A (https=)
BE (1) BE768925A (https=)
CA (1) CA954856A (https=)
DE (1) DE2131938A1 (https=)
FR (1) FR2100839B1 (https=)
GB (1) GB1351501A (https=)
HU (1) HU163640B (https=)
NL (1) NL7108858A (https=)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3922261A (en) * 1972-06-21 1975-11-25 Merck Patent Gmbh Adenosine derivative
US5066655A (en) * 1987-04-24 1991-11-19 Whitby Research, Inc. N6-substituted 9-methyladenines: a new class of adenosine receptor antagonists
US5565566A (en) * 1987-04-24 1996-10-15 Discovery Therapeutics, Inc. N6 -substituted 9-methyladenines: a new class of adenosine receptor antagonists
US5017578A (en) * 1989-06-09 1991-05-21 Hoechst-Roussel Pharmaceuticals Inc. N-heteroaryl-purin-6-amines useful as analgesic and anticonvulsant agents
US5155098A (en) * 1989-06-09 1992-10-13 Hoechst-Roussel Pharmaceuticals Inc. N-heteroaryl-purin-6-amines, and pharmaceutical compositions and methods employing them
AU654507B2 (en) * 1990-09-25 1994-11-10 Rhone-Poulenc Rorer International (Holdings) Inc. Compounds having antihypertensive and anti-ischemic properties
US5561134A (en) * 1990-09-25 1996-10-01 Rhone-Poulenc Rorer Pharmaceuticals Inc. Compounds having antihypertensive, cardioprotective, anti-ischemic and antilipolytic properties
USD337174S (en) 1991-05-16 1993-07-06 Sterling Roy J Roll on suntain oil applicator
US5432164A (en) * 1991-10-24 1995-07-11 Novo Nordisk A/S C2,N6 -disubstituted adenosine derivatives
DK62592D0 (https=) * 1992-05-14 1992-05-14 Novo Nordisk As
TW528755B (en) 1996-12-24 2003-04-21 Glaxo Group Ltd 2-(purin-9-yl)-tetrahydrofuran-3,4-diol derivatives
YU44900A (sh) 1998-01-31 2003-01-31 Glaxo Group Limited Derivati 2-(purin-9-il)tetrahidrofuran-3,4-diola
JP3933870B2 (ja) 1998-06-23 2007-06-20 グラクソ グループ リミテッド 2−(プリン−9−イル)−テトラヒドロフラン−3,4−ジオール誘導体
US7205404B1 (en) 1999-03-05 2007-04-17 Metabasis Therapeutics, Inc. Phosphorus-containing prodrugs
AU7361400A (en) * 1999-09-08 2001-04-10 Metabasis Therapeutics, Inc. Prodrugs for liver specific drug delivery
PE20060272A1 (es) 2004-05-24 2006-05-22 Glaxo Group Ltd (2r,3r,4s,5r,2'r,3'r,4's,5's)-2,2'-{trans-1,4-ciclohexanodiilbis-[imino(2-{[2-(1-metil-1h-imidazol-4-il)etil]amino}-9h-purin-6,9-diil)]}bis[5-(2-etil-2h-tetrazol-5-il)tetrahidro-3,4-furanodiol] como agonista a2a
GB0514809D0 (en) 2005-07-19 2005-08-24 Glaxo Group Ltd Compounds
AU2015217221A1 (en) 2014-02-13 2016-08-11 Ligand Pharmaceuticals, Inc. Prodrug compounds and their uses
CN106687118A (zh) 2014-07-02 2017-05-17 配体药物公司 前药化合物及其用途
CA3087932A1 (en) 2018-01-09 2019-07-18 Ligand Pharmaceuticals, Inc. Acetal compounds and therapeutic uses thereof

Also Published As

Publication number Publication date
GB1351501A (en) 1974-05-01
US3796700A (en) 1974-03-12
DE2131938A1 (de) 1972-01-05
HU163640B (https=) 1973-09-27
CA954856A (en) 1974-09-17
FR2100839A1 (https=) 1972-03-24
FR2100839B1 (https=) 1974-09-06
BE768925A (fr) 1971-11-03

Similar Documents

Publication Publication Date Title
AR204384A1 (https=)
FR2100839B1 (https=)
ATA96471A (https=)
AU1473870A (https=)
AU1146470A (https=)
AU1336970A (https=)
AU1326870A (https=)
AU1517670A (https=)
AU2130570A (https=)
AR195465A1 (https=)
AU1004470A (https=)
ATA672271A (https=)
AU1328670A (https=)
AU1603270A (https=)
AU1591370A (https=)
AU1581370A (https=)
AU2115870A (https=)
AU2112570A (https=)
AU2119370A (https=)
AU2130770A (https=)
AU1277070A (https=)
AU2131570A (https=)
AU2144270A (https=)
AU1064870A (https=)
AU1247570A (https=)